Search

Zai Lab Ltd ADR

Closed

SectorHealthcare

25.75 4.72

Overview

Share price change

24h

Current

Min

24.59

Max

25.96

Key metrics

By Trading Economics

Income

191K

-51M

Sales

6.7M

106M

EPS

-0.46

Profit margin

-47.808

Employees

1,784

EBITDA

-2.1M

-46M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+59.44% upside

Dividends

By Acuity

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

737M

2.8B

Previous open

21.03

Previous close

25.75

News Sentiment

By Acuity

38%

62%

86 / 339 Ranking in Healthcare

Zai Lab Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 wrz 2026, 23:56 UTC

Correlated Moves
News

Cohu Inc's stock rose during after-market hours, buoyed by a slight increase in the Nasdaq 100 Index amid macroeconomic developments and ongoing governance discussions.

16 wrz 2026, 23:56 UTC

News

T-Mobile US Inc appointed Jessica Uhl as CFO Designate, succeeding Peter Osvaldik, as the stock remained roughly flat in after-market trading.

16 wrz 2026, 23:51 UTC

Correlated Moves
News
Social Media

NVIDIA shares rose in after-market trading as CEO Jensen Huang discussed AI safety at Dreamforce, coinciding with Salesforce's Koa CRM model announcement.

16 wrz 2026, 23:51 UTC

Social Media
News

Alphabet Inc. will not be required to break up its ad tech unit, and GOOGL shares rose in after-market trading following a $22B chip loan report and an analyst price target increase.

16 wrz 2026, 23:51 UTC

News

Lennar Corp's shares are trading lower in after-market hours, continuing a trend from Wednesday's close and remaining below its 20-day moving average.

16 wrz 2026, 23:51 UTC

Social Media
News

Snap Inc. announced its SPECS Intelligence AI service and SPECS AR glasses priced at $2.19K, with shares trading higher after the market closed.

16 wrz 2026, 23:51 UTC

Social Media
News

A federal judge ruled Google does not need to break up its ad business, and Evercore ISI raised its price target on Alphabet to $450.

16 wrz 2026, 23:51 UTC

Correlated Moves
News

Regions Financial Corp's stock is advancing modestly in after-market trading following its announcement of a prime lending rate increase to 7.00%, effective September 2026.

16 wrz 2026, 23:51 UTC

Correlated Moves
News

Huntington Bancshares Inc raises its prime rate to 7.00% following the Fed's hike, with the stock modestly higher in after-market trading.

16 wrz 2026, 23:51 UTC

Macro News
News
Macro Event

Bitcoin is trading modestly higher, briefly surpassing $79k, despite a broader cryptocurrency market decline and $450 million in ETF outflows.

16 wrz 2026, 23:51 UTC

News

Capri Holdings Ltd shares are trading higher in after-market hours following the appointment of Catherine So as Chief Legal and Sustainability Officer, effective October 19, 2026.

16 wrz 2026, 23:46 UTC

Correlated Moves
News

Toll Brothers Inc declared a quarterly cash dividend of $0.26 per share, with the stock moving higher in after-market trading following the announcement.

16 wrz 2026, 23:41 UTC

News

Carvana Co is advancing in after-market hours, following a 1.2% increase in August retail sales data, despite recent negative sentiment regarding the Federal Reserve's rate hike.

16 wrz 2026, 23:36 UTC

News

Cinemark Holdings Inc partners with the Dallas Cowboys as the team's official movie theater, enhancing fan engagement with promotions and branding at AT&T Stadium.

16 wrz 2026, 23:36 UTC

News

AeroVironment Inc is trading lower in after-market hours, reflecting a decline from Wednesday's close, despite no specific news driving the price change.

16 wrz 2026, 23:31 UTC

Social Media
Correlated Moves
News

Tesla's stock is trading higher in after-market hours as Elon Musk retains his status as the richest American with a net worth of $908 billion.

16 wrz 2026, 23:31 UTC

News

Bloom Energy Corp is set to join the S&P 500 on September 21, boosting demand and liquidity, as the stock advances in after-market trading.

16 wrz 2026, 23:31 UTC

Correlated Moves
News

Robinhood Markets Inc. is advancing in after-market trading amid ongoing crypto regulatory uncertainty, aligning with gains in the SPDR Portfolio S&P 500 Growth ETF.

16 wrz 2026, 23:21 UTC

Social Media
Correlated Moves
News

U.S. Bancorp's prime lending rate rises to 7.00%, effective September 17, 2026, as the stock moves higher in after-market trading.

16 wrz 2026, 23:16 UTC

News

Woodward Inc. is trading lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

16 wrz 2026, 23:16 UTC

News

Dollar General Corp's stock is trading higher in after-market hours following the launch of its Simply for You by Hallmark® Holiday 2026 Collection available in 19.5k stores.

16 wrz 2026, 23:11 UTC

News

In after-hours trading, Kinder Morgan Inc shares are lower, despite strong dividend coverage and increased natural gas demand supporting future distributions.

16 wrz 2026, 23:11 UTC

News

Madrigal Pharmaceuticals' shares are declining in after-market trading following the granting of equity inducement awards to 27 new non-executive employees.

16 wrz 2026, 23:11 UTC

News

Roivant Sciences Ltd shares rise in after-market trading following Stifel's initiation of coverage with a Buy rating and a price target of $51.00.

16 wrz 2026, 23:07 UTC

News

Southwest Airlines shares traded lower in after-market hours following CFO comments on reduced capacity growth and 737 MAX 7 delivery expectations.

16 wrz 2026, 23:07 UTC

Correlated Moves
News

JPMorgan Chase CEO Jamie Dimon noted a "mini boom" in small business applications, with 4.3 million filed this year, as shares remain roughly flat in after-market trading.

16 wrz 2026, 23:06 UTC

News

World Kinect Corporation announced a quarterly cash dividend of $0.23 per share, and the stock is trading higher in after-market hours.

16 wrz 2026, 23:06 UTC

Correlated Moves
News

Zeta Global Holdings Corp announced an expanded speaker lineup for its Zeta Live 2026 event, contributing to a higher stock price in after-market trading.

16 wrz 2026, 23:06 UTC

Correlated Moves
News

Truist Financial Corp has advanced in after-market trading following a rise in the prime lending rate to 7%, enhancing banks' net interest income.

16 wrz 2026, 23:06 UTC

Correlated Moves
News

Citizens Financial Group's shares are slightly higher in after-market trading following its announcement of a prime lending rate increase to 7.00% effective September 17, 2026.

Peer Comparison

Price change

Zai Lab Ltd ADR Forecast

Price Target

By TipRanks

59.44% upside

12 Months Forecast

Average 39.333 USD  59.44%

High 45 USD

Low 36 USD

Based on 3 Wall Street analysts offering 12 month price targets forZai Lab Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Sentiment

By Acuity

86 / 339 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat